News
2023.01.06
Innovation
An Institut Pasteur team has successfully developed a pentavalent vaccine against the five pathogenic arenaviruses...
News
2022.12.07
Innovation
SpikImm, a biotech company founded in 2021 by Truffle Capital in collaboration with the Institut Pasteur, has been...
News
2022.07.19
Innovation
News
2022.05.16
Innovation
The Institut Pasteur and Moderna have signed a Master Material Transfer Agreement (MMTA) to enable researchers of the...
News
2022.05.12
Innovation
Fundamentally applied!
From basic research to product: the innovation potential of the Institut Pasteur’s continuum
...
News
2022.05.12
Innovation
Scientist at the Institut Pasteur- TheraVectys Joint Laboratory have demonstrated the efficacy of their lentiviral...
News
2022.04.14
Santé - Maladies infectieuses
SPK001, the monoclonal antibody developed by SpikImm, a biotech company founded by the Institut Pasteur and Truffle...
News
2022.02.28
Innovation
The exclusive worldwide license agreement signed between the Institut Pasteur and Meletios Therapeutics, a French...
News
2021.12.09
Innovation
At the intersection of public and private research, the 3IA institutes create the ideal conditions for collaboration...